Economic News GLP-1 Feud Ends: NOVO, HIMS Join Forces (Again) To Sell Obesity DrugsMarch 7, 20260 After a long-standing feud, Novo Nordisk and telehealth firm Hims & Hers Health are set to announce a surprising partnership…